INmune Bio Stock (NASDAQ: INMB) stock price, news, charts, stock research, profile.
You can purchase shares of INmune Bio (NASDAQ:INMB) through any online brokerage.
Other companies in INmune Bio’s space includes: Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR) and Zentalis Pharma (NASDAQ:ZNTL).
INmune Bio has a consensus price target of $18.29.
The stock price for INmune Bio (NASDAQ: INMB) is $8.59 last updated February 21, 2025 at 4:01 PM EST.
There are no upcoming dividends for INmune Bio.
INmune Bio’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for INmune Bio.
INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.